News
Piper Sandler Reiterates Neutral on Viatris, Raises Price Target to $13
28 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Looking Into Viatris's Recent Short Interest
15 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?
28 Feb 24
Analyst Color, Cryptocurrency, Large Cap, Macro Economic Events, Mid Cap, REIT, Broad U.S. Equity ETFs, Specialty ETFs, New ETFs, Small Cap, Top Stories, Economics, Federal Reserve, Intraday Update, Analyst Ratings, Tech, ETFs, Real Estate
Viatris Q4 Adjusted EPS $0.62 Misses $0.65 Estimate, Sales $3.83B Miss $3.87B Estimate
28 Feb 24
Earnings, News
Earnings Scheduled For February 28, 2024
28 Feb 24
Earnings
Viatris And Idorsia Forge Global Partnership For Breakthrough Heart Attack Treatments
28 Feb 24
Equities, News, Contracts, Markets, General
Viatris And Idorsia Enter Into Significant Global Research And Development Collaboration
28 Feb 24
News
5 Value Stocks In The Healthcare Sector
26 Feb 24
News
(VTRS) - Analyzing Viatris's Short Interest
23 Jan 24
Short Sellers, Short Ideas, Trading Ideas
Press releases
Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
16 Apr 24
Press Releases
Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada
15 Apr 24
Press Releases
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
27 Mar 24
Press Releases
Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris
11 Mar 24
Press Releases
Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
28 Feb 24
Earnings, Press Releases
Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration
28 Feb 24
News, Contracts, Press Releases
Idorsia and Viatris enter into a significant global research and development collaboration
28 Feb 24
Press Releases
Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results
5 Feb 24
Press Releases